"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

For now, it’s up to the courts whether the Trump administration can continue on a path of dramatically downsizing the bureau.

Zooming out, the Beige Book confirms what price action has been whispering: tariff fatigue is bleeding into the real economy. Consumer sentiment’s shaky, hiring’s slowing, and businesses are caught ...

BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, brain-inspired AI, today announced the integration of its NPUs with RISC-V cores from Andes Technology, ...

Despite successful operations against ransomware gangs in 2024, ransomware was still the most pervasive threat to critical infrastructure in the US last year, according to the FBI’s latest Internet ...

DFA US Vector Equity Fund earns a High Process ... In recent months, the strategy also had less Yield factor exposure than its peers. More information on a fund and its respective category's ...

Abeona Therapeutics' pz-cel gene therapy shows the most durable wound healing in RDEB patients. See why I rate ABEO stock a ...

Even if nationalist voters don't want secession, they are proud of their representatives who defend them at every opportunity ...

AppLovin shares have recently been in the spotlight, but not in a good way. Check out why I rate APP stock a buy.

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

I think that's the question that the market is trying to answer right now, and I think this added uncertainty is really the main reason why we're seeing video shares down today. I think the market has ...

Fifteen organizations have at least $100 million in active unobligated funding, about 71% of the total available funding left ...